Qingyuan Zhang
7PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 28, 2026
Becotatug Vedotin in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Multicenter, Phase IIa Trial.Liqiong Xue, Yaqian Han, Qingyuan Zhang
|Feb 01, 2022
Serum amyloid A 1 induces suppressive neutrophils through the Toll-like receptor 2-mediated signaling pathway to promote progression of breast cancer.Xingjian Niu, Lei Yin, Xudong Yang
|May 19, 2021
Sodium/glucose cotransporter 1-dependent metabolic alterations induce tamoxifen resistance in breast cancer by promoting macrophage M2 polarization.Xingjian Niu, Jianli Ma, Jingtong Li
|Jan 16, 2021
HMGB1 is a key factor for tamoxifen resistance and has the potential to predict the efficacy of CDK4/6 inhibitors in breast cancer.Han Zhang, Jinlu Wang, Jingtong Li
|May 08, 2020
Sodium-Dependent Glucose Transporter 1 (SGLT1) Stabled by HER2 Promotes Breast Cancer Cell Proliferation by Activation of the PI3K/Akt/mTOR Signaling Pathway in HER2+ Breast Cancer.Jinlu Wang, Hongfei Ji, Xingjian Niu
Pageof 2
